Bewilligte Beiträge SNF 2007 / Subsides FNS accordés en 2007
Bewilligte Beiträge SNF 2007 / Subsides FNS accordés en 2007
Bewilligte Beiträge SNF 2007 / Subsides FNS accordés en 2007
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Verantwortliche/r<br />
Beitragsempfänger/in<br />
Bénéficiaire responsable<br />
Titel<br />
Titre<br />
Universität<br />
Université<br />
Weitere<br />
Beitragsempfänger/inn<strong>en</strong><br />
Autres bénéficiaires<br />
Projekttitel<br />
Titre de projet<br />
Pharmakologie, Pharmazie<br />
Pharmacologie, pharmacie<br />
Juillerat-Jeanneret Luci<strong>en</strong>ne Dr. Université de Lausanne Hofmann Heinrich Multifunctional superparamagnetic nanoparticles for magnetically-<strong>en</strong>hanced targeted drug delivery. An<br />
in vitro study of the mechanisms of cell uptake and interactions with cell functions<br />
Dauer<br />
(M)<br />
Durée<br />
Beitragsnummer<br />
Numéro du<br />
subside<br />
Betrag<br />
Montant<br />
42 3152A0-105705 35'779 *<br />
Quitterer Ursula Maria Prof. ETH Zürich Mechanisms of dysfunction of angiot<strong>en</strong>sin II receptors in cardiovascular disease 36 310000-115969 296'000<br />
Reich<strong>en</strong> Jürg Prof. Universität Bern Shaw Sidney George, Stickel<br />
Felix<br />
Liver fibrosis: targetting mTOR, ras and differ<strong>en</strong>t G-proteins in man and rat 36 320000-117725 260'000<br />
Medizinische Mikrobiologie<br />
Microbiologie médicale<br />
Berger-Bächi Brigitte Prof. Universität Zürich G<strong>en</strong>etic and molecular basis of methicillin and glycopeptide resistance in Staphylococcus aureus 36 310000-117707 335'000<br />
François Patrice Philippe Dr. Université de G<strong>en</strong>ève Schr<strong>en</strong>zel Jacques Large-scale evaluation of bacterial g<strong>en</strong>ome cont<strong>en</strong>t for the id<strong>en</strong>tification of epidemiological and<br />
virul<strong>en</strong>ce basis in MRSA<br />
36 3100A0-116075 227'000<br />
Greub Gilbert Daniel Dr. Université de Lausanne Interactions of chlamydia-like organisms with macrophages and their role as ag<strong>en</strong>ts of pneumonia 36 3200B0-116445 260'000<br />
Monod Michel Dr. Université de Lausanne Hauser Philippe, Panizzon<br />
R<strong>en</strong>ato G.<br />
Ruggli Nicolas Dr. Universität Bern Tratschin Jon Duri, Summerfield<br />
Arthur<br />
Experim<strong>en</strong>telle Medizin<br />
Médecine expérim<strong>en</strong>tale<br />
Virul<strong>en</strong>ce factors of dermatophytes and other keratinolytic fungi 36 320000-117964 377'000<br />
Molecular mechanisms of the counteraction of interferon-a/b induction by classical swine fever virus 36 3100A0-116608 227'000<br />
Experim<strong>en</strong>telle Krebsforschung<br />
Recherches expérim<strong>en</strong>tales sur le cancer<br />
Borsig Lubor Dr. Universität Zürich Leukocytes as facilitators of metastasis 36 3100A0-116295 260'000<br />
Bourquin Jean-Pierre Dr. Universität Zürich Importance of leukemia-initiating cells in the poor response to chemotherapy in childhood very high<br />
risk acute lymphoblastic leukemia<br />
36 310000-118392 296'000<br />
Carbone Giuseppina M. R. Dr. Sonstige Catapano Carlo, Bertoni<br />
Francesco<br />
The epithelial specific ETS transcription factor-3 (ESE-3) as a tumor suppressor in prostate cancer 36 3100A0-118113 227'000<br />
Dupertuis Yves Marc Dr. Université de G<strong>en</strong>ève Pichard Claude, Buchegger<br />
Franz, Allal Abdelkarim Saïd<br />
Modulation of human colorectal ad<strong>en</strong>ocarcinoma radio-s<strong>en</strong>sitivity by polyunsaturated fatty acids 36 310000-116738 197'000<br />
Frese Steff<strong>en</strong> Rainer Dr. Universität Bern Treatm<strong>en</strong>t of established, chemically induced non-small cell lung cancer with tumor necrosis factorrelated<br />
apoptosis-inducing ligand (TRAIL)<br />
12 3100A0-118324 54'508<br />
Huber Marcel Dr. Université de Lausanne Hohl Daniel The role of the proto-oncog<strong>en</strong>e Bcl-3 in skin carcinog<strong>en</strong>esis 36 3100A0-118093 296'000<br />
Mäcke Helmut R. Prof. Universität Basel Müller-Brand Jan, Herrmann<br />
Richard, Forrer Flavio<br />
Targeted radiodiagnosis and therapy with use of small (regulatory) peptides 15 320000-118333 177'084<br />
Neri Dario Prof. ETH Zürich Understanding and improving the selective molecular targeting of neovasculature 60 3100A0-105919 319'334<br />
Niggli Felix Dr. Universität Zürich Schäfer Beat Innovative treatm<strong>en</strong>t approaches for Ewing's sarcoma 36 3100A0-118035 227'000<br />
Novak-Hofer Ilse Dr. Paul Scherrer Institut Grünberg Jürg<strong>en</strong>, Schubiger Pius Combination of radioimmunotherapy with growth inhibition for antibody-based therapy of L1<br />
36 3100A0-116185 183'050<br />
August<br />
expressing metastases<br />
Pruschy Martin N. Prof. Universität Zürich Jochum Wolfram, Ohlerth Inhibition of angiog<strong>en</strong>esis and tumor proliferation: Influ<strong>en</strong>ce of differ<strong>en</strong>t treatm<strong>en</strong>t modalities on the 12 3100A0-116808 111'650<br />
Stefanie<br />
tumor micro<strong>en</strong>vironm<strong>en</strong>t<br />
Ris Hans-Beat Friedrich Prof. Université de Lausanne van d<strong>en</strong> Bergh Hubert,<br />
Photodynamic therapy: a pathway for <strong>en</strong>hanced doxorubicin delivery to tumors during isolated lung 36 310000-118222 260'000<br />
Decosterd Laur<strong>en</strong>t, Andrejevic-<br />
Blant Snezana<br />
perfusion<br />
<strong>Bewilligte</strong> <strong>Beiträge</strong> <strong>SNF</strong> / <strong>Subsides</strong> <strong>accordés</strong> <strong>FNS</strong> <strong>2007</strong> | 47
Change language